Le Lézard10h
International Stroke Conference 2025: Remedy Pharmaceuticals Unveils Landmark CIRARA® Data Demonstrating Significant Improvements in Stroke Outcomes
Remedy Pharmaceuticals, a leader in stroke drug development today announced efficacy data from the Phase 2 GAMES-RP and Phase 3 CHARM studies of CIRARA (intravenous glyburide) for the treatment of ...
Intra-arterial tenecteplase beneficial for large vessel occlusion
For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful ...
HealthDay on MSN8h
ASA: Alteplase Ups Outcomes at 4.5 to 24 Hours After Symptom Onset in Acute Ischemic Stroke
For patients with acute ischemic stroke (AIS) whose symptoms began 4.5 to 24 hours earlier, alteplase is associated w ...